The effects of dexamethasone treatment on immunoreactive and bioactive insulin-like growth factors (IGFs) and IGF-binding proteins in normal male volunteers.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Journal of Endocrinology

• Publication date

  1993-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1677/JOE.0.1360525PMID 7682595
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factor binding protein-3: biochemistry and physiology.

  1992cited by this paper
• Hormonal regulation of insulin-like growth factor (IGF)-binding proteins secreted by isolated sheep thyroid epithelial cells: relationship with iodine organification.

  1991cited by this paper
• The insulin-like growth factor binding protein-1 in low and high insulin responders before and during dexamethasone treatment.

  1991cited by this paper
• Dexamethasone treatment in man induces changes in 24-hour growth hormone (GH) secretion profile without altering total GH released.

  1991cited by this paper
• Variables controlling the secretion of insulin-like growth factor binding protein-2 in normal human subjects.

  1991cited by this paper
• Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.

  1991cited by this paper
• Different tissue distribution and hormonal regulation of messenger RNAs encoding rat insulin-like growth factor-binding proteins-1 and -2.

  1990cited by this paper
• A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency.

  1990cited by this paper
• Acute administration of corticoids: a new and peculiar stimulus of growth hormone secretion in man.

  1990cited by this paper
• Dexamethasone increases hepatic insulin-like growth factor binding protein-1 (IGFBP-1) mRNA and serum IGFBP-1 concentrations in the rat.

  1990cited by this paper
• The 25-kilodalton insulin-like growth factor (IGF)-binding protein inhibits both basal and IGF-I-mediated growth of chick embryo pelvic cartilage in vitro.

  1990cited by this paper
• Dual and selective actions of glucocorticoids upon basal and stimulated growth hormone release in man.

  1990cited by this paper
• THE GROWTH HORMONE INDEPENDENT INSULIN‐LIKE GROWTH FACTOR‐I BINDING PROTEIN BP‐28 IS ASSOCIATED WITH SERUM INSULIN‐LIKE GROWTH FACTOR‐I INHIBITORY BIOACTIVITY IN ADOLESCENT INSULIN‐DEPENDENT DIABETICS

  1990cited by this paper
• Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects.

  1989cited by this paper
• INSULIN‐LIKE GROWTH FACTOR 1 AND BONE TURNOVER IN GLUCOCORTICOID‐TREATED AND CONTROL SUBJECTS

  1989cited by this paper
• Serum levels of insulin‐like growth factor (IGF) I, II and IGF binding protein in diabetic adolescents treated with continuous subcutaneous insulin infusion

  1989cited by this paper
• Dexamethasone inhibits growth hormone induction of insulin-like growth factor-I (IGF-I) messenger ribonucleic acid (mRNA) in hypophysectomized rats and reduces IGF-I mRNA abundance in the intact rat.

  1989cited by this paper
• Lack of diurnal rhythm of low molecular weight insulin-like growth factor binding protein in patients with Cushing's disease.

  1989cited by this paper
• Depending on the time of administration, dexamethasone potentiates or blocks growth hormone-releasing hormone-induced growth hormone release in man.

  1988cited by this paper
• Effect of human growth hormone-releasing hormone on GH secretion in Cushing's syndrome and non-endocrine disease patients treated with glucocorticoids.

  1988cited by this paper
• A specific radioimmunoassay for insulin-like growth factor II: the interference of IGF binding proteins can be blocked by excess IGF-I.

  1988cited by this paper
• ORCADIAN VARIATION OF GH‐INDEPENDENT IGF‐BINDING PROTEIN IN DIABETES MELLITUS AND ITS RELATIONSHIP TO INSULIN. A NEW ROLE FOR INSULIN?

  1988cited by this paper
• Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein.

  1988cited by this paper
• Glucocorticoid effects on somatomedins and somatomedin inhibitors.

  1985cited by this paper
• Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy.

  1982cited by this paper
• Somatomedin A levels in patients with Cushing's disease.

  1981cited by this paper
• Partial purification and characterization of a binding protein for insulin-like activity (ILAs) in human amniotic fluid: a possible inhibitor of insulin-like activity.

  1979cited by this paper
• Plasma levels, half-life values, and correlation with physiologic assays for growth and immunity.

  1978cited by this paper
• A rapid simplified bioassay for somatomedin.

  1978cited by this paper
• Cartilage sulfation and serum somatomedin in rats during and after cortisone-induced growth arrest.

  1976cited by this paper
• Glucocorticoid therapy in children. Effect on somatomedin secretion.

  1975cited by this paper
• Suppressive effect of glucocorticoid on arginine-induced growth hormone release in normal subjects.

  1974cited by this paper
• Growth hormone and cortisol responsiveness in Cushing's syndrome. Relation to a possible central nervous system etiology.

  1972cited by this paper
• Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone.

  1969cited by this paper
• Conversion of proline U-C14 to labeled hydroxyproline by rat cartilage in vitro: effects of hypophysectomy, growth hormone, and cortisol.

  1962cited by this paper
• Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children.

  1956cited by this paper

• Prednisolone at a therapeutic dose is not detrimental to mouse oocyte competence

  2025cites this paper
• Current Challenges and Future Directions in the Assessment of Glucocorticoid Status

  2024cites this paper
• Glucocorticoid supplementation during ovulation induction for assisted reproductive technology: a systematic review and meta-analysis

  2023cites this paper
• Alterations of materno-placento-fetal glucose homeostasis after a single course of antenatal betamethasone.

  2023cites this paper
• The effect of androgen administration on in vitro fertilization outcome in poor responders undergoing ovarian stimulation with microdose protocol: A randomized clinical trial.

  2022cites this paper
• The association between insulin-like growth factor 1 levels within reference range and early postoperative remission rate in patients with Cushing’s disease

  2021cites this paper
• Glucocorticoid therapy in assisted reproduction

  2021cites this paper
• The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis

  2019cites this paper
• The insulin-like growth factor-I receptor stimulating activity (IRSA) in health and disease.

  2019cites this paper
• Combined antenatal and postnatal steroid effects on fetal and postnatal growth, and neurological outcomes in neonatal rats.

  2019cites this paper
• Targeted Searches of the Electronic Health Record and Genomics Identify an Etiology in Three Patients with Short Stature and High IGF-I Levels

  2019cites this paper
• Circulating insulin-like growth factor I modulates mood and is a biomarker of vulnerability to stress: from mouse to man

  2018cites this paper
• The effect of testosterone gel on fertility outcomes in women with a poor response in in vitro fertilization cycles: A pilot randomized clinical trial

  2018cites this paper
• Effects of dexamethasone and insulin alone or in combination on reproduction in dairy cows in early lactation

  2017cites this paper
• Effects of Prednisolone on Serum and Tissue Fluid IGF‐I Receptor Activation and Post‐Receptor Signaling in Humans

  2017influential citation
• Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI.

  2017cites this paper
• Hippocampal gene expression, serum cortisol level, and spatial memory in rats exposed to hypergravity

  2017cites this paper
• Raised serum levels of IGFBP-1 and IGFBP-2 in idiopathic pulmonary fibrosis

  2016cites this paper
• Prenatal stress leads to changes in IGF-1 binding proteins network in the hippocampus and frontal cortex of adult male rat.

  2014cites this paper
• Potential of treatment-specific protein biomarker profiles for detection of hormone abuse in cattle.

  2013cites this paper
• Insulin-like growth factor I correlates with MELD and returns to normal level after liver transplantation.

  2013cites this paper
• Dexamethasone Improve Ovarian Response to Ovulation Induction Drugs in Women Over 35 Years

  2012cites this paper
• Prednisolone reduces the ability of serum to activate the IGF1 receptor in vitro without affecting circulating total or free IGF1.

  2012cites this paper
• Placental malaria-associated inflammation disturbs the insulin-like growth factor axis of fetal growth regulation.

  2011cites this paper
• Serum insulin-like growth factor-1 measurements in dogs: performance characteristics of an automated assay and study of some sources of variation.

  2011influential citation
• Serum IGF-I, Life Style, and Risk of Alzheimer’s disease

  2010cites this paper
• Diabetes, Insulin and Alzheimer's Disease

  2010cites this paper
• Is There A Place for Adjuvant Therapy in IVF?

  2010influential citation
• Placental Malaria-Associated Inflammation Disturbs the Insulin-like Growth Factor Axis of Fetal Growth Regulation

  2010cites this paper
• Poor Response to Controlled Ovarian Hyperstimulation

  2009cites this paper
• Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis.

  2008cites this paper
• DEXAMETHASONE AS A SUPPLEMENT FOR EXOGENOUS GONADOTROPIN TO IMPROVE OVARIAN RESPONSE OF WOMEN OVER 35 YEARS UNDERGOING IVF/ICSI CYCLES

  2007cites this paper
• The insulin-like growth factor (IGF)-system in active ulcerative colitis and Crohn's disease: relations to disease activity and corticosteroid treatment.

  2007cites this paper
• IGF-I measurements in the diagnosis of adult growth hormone deficiency

  2007cites this paper
• Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study

  2006cites this paper
• Thyroid hormone and insulin-like growth factor-I in patients with multiple myeloma treated with melphalan and prednisone.

  2006cites this paper
• Influence of a single course of antenatal betamethasone on the maternal-fetal insulin-IGF-GH axis in singleton pregnancies.

  2006cites this paper
• Clomiphene citrate and dexamethazone in treatment of clomiphene citrate-resistant polycystic ovary syndrome: a prospective placebo-controlled study.

  2006cites this paper
• Recombinant Human Growth Hormone Treatment after Liver Transplantation in Childhood: The 5-year Outcome

  2005influential citation
• INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS-1 AND -3 AND SEX HORMONE-BINDING GLOBULIN: STUDIES ON REGULATION OF SYNTHESIS IN VITRO, AND CLINICAL ASPECTS

  2005cites this paper
• The insulin-like growth factor system in advanced breast cancer.

  2004cites this paper
• Differential kinetics of serum and cervical insulin-like growth factor-binding protein-1 during mifepristone-misoprostol-induced medical termination of early pregnancy.

  2004cites this paper
• Different states of clinical control are associated with changes in IGF‐I and IGFBPs in children with congenital adrenal hyperplasia due to 21‐hydroxylase deficiency

  2004cites this paper
• The IGF and IGFBP System in Insulin Resistance and Diabetes Mellitus

  2004cites this paper
• Effects of inhaled fluticasone propionate in children less than 2 years old with recurrent wheezing

  2004cites this paper
• Effect of short-term prednisone use on blood flow, muscle protein metabolism, and function.

  2004cites this paper
• Mechanisms of growth in small preterm infants and early life origins of adult cardiovascular disease

  2003influential citation
• Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate.

  2003influential citation
• Serum IGF-1 concentrations following pituitary desensitization do not predict the ovarian response to gonadotrophin stimulation prior to IVF.

  2003influential citation
• Clinical management of low ovarian response to stimulation for IVF: a systematic review.

  2003cites this paper
• Serum levels of insulin-like growth factor I and its binding proteins in health and disease.

  2003cites this paper
• Insulin-Like Growth Factors and Their Binding Proteins

  2003cites this paper
• Effect of Dexamethasone Treatment on Serum GH, IGF-I, and the Binding Proteins IGFBP-1 and -3 in Ventilated Very Preterm Infants

  2003cites this paper
• Glucocorticoid-induced effects on the growth plate and the IGF system

  2003cites this paper
• Growth in infants with bronchopulmonary dysplasia, endocrine and pulmonary aspects : clinical and follow-up studies

  2003influential citation
• Influência dos glicocorticóides sobre o eixo somatotrófico

  2003cites this paper
• Insulin-Like Growth Factor (IGF)-I, IGF Binding Protein (IGFBP)-3, Phosphoisoforms of IGFBP-1 and Postnatal Growth in Very-Low-Birth-Weight Infants

  2003cites this paper
• Role of the somatotropic axis in the mammalian metabolism.

  2002cites this paper
• IGF-I, IGF binding protein (IGFBP)-3, phosphoisoforms of IGFBP-1, and postnatal growth in very low birth weight infants.

  2002cites this paper
• Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment.

  2002cites this paper
• Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components.

  2002cites this paper
• Glucocorticoids are not necessary for the inhibitory effect of endotoxic shock on serum IGF-I and hepatic IGF-I mRNA.

  2002cites this paper
• Low free and total insulinlike growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment

  2002cites this paper
• Poor ovarian response to gonadotrophin stimulation — The role of adjuvant treatments

  2002influential citation
• Markers of Type I and Type III Collagen Turnover, Insulin-Like Growth Factors, and Their Binding Proteins in Cord Plasma of Small Premature Infants: Relationships with Fetal Growth, Gestational Age, Preeclampsia, and Antenatal Glucocorticoid Treatment

  2001cites this paper
• IGFs and IGF-binding proteins in short children with steroid-dependent nephrotic syndrome on chronic glucocorticoids: changes with 1 year exogenous GH.

  2001cites this paper
• Use of mutagenesis to probe IGF-binding protein structure/function relationships.

  2001cites this paper
• Dexamethasone treatment at birth enhances neonatal growth in swine.

  2001cites this paper
• Dexamethasone does not increase IGF-I and IGFBP-3 levels in man in the absence of endogenous GH

  2001cites this paper
• Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors.

  2001cites this paper
• Factors regulating insulin-like growth factor binding protein-3 secretion from human hepatoma (HepG2) cells.

  2001cites this paper
• Recombinant human IGF-I does not modify the ACTH and cortisol responses to hCRH and hexarelin, a peptidyl GH secretagogue, in humans

  2001cites this paper
• Low-dose dexamethasone augments the ovarian response to exogenous gonadotrophins leading to a reduction in cycle cancellation rate in a standard IVF programme.

  2001cites this paper
• No Influence of Prednisolone on IGFBP-3 Proteolysis in Healthy Young Men

  2001cites this paper
• Antenatal dexamethasone and the growth hormone-insulin-like growth factor axis.

  2000cites this paper
• Integrity of the growth hormone/insulin-like growth factor system is maintained in patients with chronic fatigue syndrome.

  2000influential citation
• Impact of Inhaled and Intranasal Corticosteroids on the Growth of Children

  2000cites this paper
• Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone.

  2000cites this paper
• Dexamethasone ester treatment alters insulin-like growth factor-I, its binding proteins and thyroid status in finishing calves

  2000cites this paper
• The metabolic effect of antenatal corticosteroid therapy.

  2000cites this paper
• IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man

  1999cites this paper
• Advances in the recognition and treatment of endocrine complications in children with chronic illness.

  1999cites this paper
• Correlation between cortisol and insulin‐like growth factor‐binding proteins (IGFBPs) under physiological conditions in children

  1999cites this paper
• Serum free insulin-like growth factor-I is dose-dependently decreased by methylprednisolone and related to body weight changes in rats.

  1999cites this paper
• Circulating levels of human insulin‐like growth factor binding protein‐6 (IGFBP‐6) in health and disease as determined by radioimmunoassay

  1999cites this paper
• IGFs in the Evaluation of Acromegaly

  1999cites this paper
• Endurance Training and its Effect upon the Activity of the GH-IGFs System in the Elderly

  1998cites this paper
• Influence of treatment with onapristone on the IGF-system in breast cancer patients.

  1998cites this paper
• Determinants of serum insulin‐like growth factor I in growth hormone deficient adults as compared to healthy subjects

  1998cites this paper
• Alcohol withdrawal-induced change in lipoprotein(a): association with the growth hormone/insulin-like growth factor-I (IGF-I)/IGF-binding protein-1 (IGFBP-1) axis.

  1998cites this paper
• Maternal and fetal insulin-like growth factors and their binding proteins in the second and third trimesters of human pregnancy.

  1998influential citation
• Molecular regulation of insulin-like growth factor-I and its principal binding protein, IGFBP-3.

  1998cites this paper
• Antenatal dexamethasone therapy does not affect circulating concentrations of insulin-like growth factor binding protein-1.

  1998influential citation
• Treatment of Peripubertal Children after Renal Transplantation (RTX) with Recombinant Human Growth Hormone: Auxological Data and Effects on Insulin-like Growth Factor-I (IGF-Γ) and IGF-Binding Protein-3 (IGFBP-3) during 24 Months

  1998cites this paper
• Serum insulin-like growth factors and their binding proteins in patients with hepatic failure and after liver transplantation.

  1998cites this paper
• The Effects of Glucocorticoids (Dexamethasone) on Insulin-Like Growth Factor-I, IGF-Binding Proteins, and Growth in Chickens

  1998cites this paper
• Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia

  1997cites this paper
• Insulin‐like growth factor‐binding protein‐2 in patients with prostate carcinoma and benign prostatic hyperplasia

  1997cites this paper
• Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone

  1997cites this paper
• Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients.

  1997cites this paper